Cargando…

Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination

Detalles Bibliográficos
Autor principal:	Young, Jo-Anne H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. 2021
Materias:	The Bottom Line
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384341/ https://www.ncbi.nlm.nih.gov/pubmed/34452720 http://dx.doi.org/10.1016/j.jtct.2021.08.003

Ejemplares similares

A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era
por: Allan, David S.
Publicado: (2021)

Comprehensive mapping of O‐glycosylation in flagellin from Campylobacter jejuni 11168: A multienzyme differential ion mobility mass spectrometry approach
por: Ulasi, Gloria N., et al.
Publicado: (2015)

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Establishment and characterization of METON myoepithelioma cell line derived from human palatal myoepithelioma: apical reference to the diverse differentiation potential
por: Suzuki, Minako, et al.
Publicado: (2013)

HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity
por: Kasai, Fumio, et al.
Publicado: (2018)

Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations
por: Kasai, Fumio, et al.
Publicado: (2020)

Establishment of Down’s syndrome periodontal ligament cells by transfection with SV40T-Ag and hTERT
por: Asakawa, Takeyoshi, et al.
Publicado: (2021)

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models
por: Bangerter, Jana Lucia, et al.
Publicado: (2022)

Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type
por: Gao, Yi, et al.
Publicado: (2023)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation
por: Sherman, Amy C., et al.
Publicado: (2023)

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients
por: Kokogho, Afoke, et al.
Publicado: (2023)

Infections in Recipients of Hematopoietic Stem Cell Transplants
por: Young, Jo-Anne H., et al.
Publicado: (2015)

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
por: Leclerc, Mathieu, et al.
Publicado: (2022)

Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)

Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2021)

Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients
por: Wu, Xi, et al.
Publicado: (2022)

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients
por: Thümmler, Laura, et al.
Publicado: (2022)

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients
por: Maillard, Alexis, et al.
Publicado: (2021)

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Saraceni, Francesco, et al.
Publicado: (2021)

Immunogenicity of Sars-Cov-2 Vaccination in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2022)

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Meyer, Thomas, et al.
Publicado: (2022)

1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022)

HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
por: Villemonteix, Juliette, et al.
Publicado: (2023)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Ali, Haris, et al.
Publicado: (2021)

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
por: Maillard, Alexis, et al.
Publicado: (2022)

Vaccination of Hematopoietic Stem Cell Transplantation Recipients: Perspective in Korea
por: Lee, Dong-Gun
Publicado: (2013)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases
por: Greco, Raffaella, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients
por: Peghin, Maddalena, et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

P1613: SINGLE-CELL ANALYSIS FOLLOWING SARS-COV-2 MRNA VACCINE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
por: Tranter, E., et al.
Publicado: (2022)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Commentary on STOP DIABETES study
por: Suvarna, Viraj, et al.
Publicado: (2019)

CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial
por: Nath, Baishali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jhj1rtno0759uknvmp9mt9npqk